{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T variant associated with increased protein aggregation and toxicity"
        },
        {
          "HGVS": "NM_001126112.3:c.91G>C",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "C",
            "position": "91"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P variant linked to early-onset Parkinson's disease"
        },
        {
          "HGVS": "NM_001126112.3:c.139G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "139"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K variant associated with familial Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005234"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells stably expressing SNCA variants were used for protein aggregation analysis."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T variant showed 2.5-fold increase in protein aggregation compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.91G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A30P variant demonstrated 3.2-fold higher toxicity in neuronal cultures."
        },
        {
          "Variant": "NM_001126112.3:c.139G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K variant exhibited 1.8-fold increase in Lewy body-like inclusions."
        }
      ],
      "Replicates": "3 biological replicates with n=6 per group",
      "Controls": "Wild-type SNCA-expressing cells and vehicle-treated controls",
      "Statistical Methods": "ANOVA with post-hoc Tukey's test (p<0.05)",
      "Thresholds": "Aggregation levels >1.5-fold increase over wild-type considered significant",
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Animal model",
        "Material Name": "Transgenic mice",
        "Description": "SNCA variant-expressing transgenic mice were analyzed for neuronal degeneration."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mice showed 40% loss of dopaminergic neurons in substantia nigra."
        },
        {
          "Variant": "NM_001126112.3:c.91G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A30P mice exhibited 35% reduction in TH-positive neurons."
        },
        {
          "Variant": "NM_001126112.3:c.139G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K mice demonstrated 25% decrease in nigral dopamine content."
        }
      ],
      "Replicates": "n=10 per group",
      "Controls": "Non-transgenic littermates",
      "Statistical Methods": "Student's t-test (p<0.01)",
      "Thresholds": "Neuronal loss >20% considered significant",
      "Approved Assay": "Yes"
    }
  ]
}